Anja Schweizer
-
- Diabetes Treatment and Management 58
- Diabetes Management and Research 23
- Cell Biology top 0.5%
- Cellular transport and secretion 19
- Oncology top 1%
- Peptidase Inhibition and Analysis 16
- Molecular Biology top 1%
- Metabolism, Diabetes, and Cancer 21
- Surgery top 1%
- Pancreatic function and diabetes 27
-
- Heart Failure Treatment and Management 15
- Cardiovascular Function and Risk Factors 9
- Co-authors
- S. DejagerJames E. FoleyBo ÅhrénDavid MillsJack RohrerHans-Peter HauriStuart KornfeldMichelle A. Baron
- Journals
- Diabetes Obesity and Metabolism (11 papers)Vascular Health and Risk Management (9 papers)The Journal of Clinical Endocrinology & Metabolism (7 papers)
- Partner nations
- SwitzerlandUnited StatesSweden
In The Last Decade
Anja Schweizer
113 papers receiving 9.3k citations
Hit Papers
Peers
Comparison fields: 5 of 130
- Endocrinology, Diabetes and Metabolism 5.2k
- Cell Biology 2.0k
- Oncology 1.7k
- Molecular Biology 4.2k
- Surgery 2.7k
Countries citing papers authored by Anja Schweizer
This map shows the geographic impact of Anja Schweizer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anja Schweizer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anja Schweizer more than expected).
Fields of papers citing papers by Anja Schweizer
This network shows the impact of papers produced by Anja Schweizer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anja Schweizer. The network helps show where Anja Schweizer may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Anja Schweizer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 5 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 4 | |
| 5 | 2023 | 3 | |
| 6 | 2022 | 9 | |
| 7 | 2021 | 25 | |
| 8 | 2015 | 46 | |
| 9 | 2014 | 13 | |
| 10 | 2013 | 26 | |
| 11 | 2012 | 17 | |
| 12 | 2011 | 136 | |
| 13 | 2008 | 6 | |
| 14 | 2008 | 109 | |
| 15 | 2007 | 314 | |
| 16 | 2006 | 241 | |
| 17 | 2005 | 11 | |
| 18 | Inhibition of Dipeptidyl Peptidase-4 Reduces Glycemia, Sustains Insulin Levels, and Reduces Glucagon Levels in Type 2 Diabetesbreakdown → | 2004 | 607 |
| 19 | 1999 | 73 | |
| 20 | 1995 | 35 |
About Anja Schweizer
Anja Schweizer is a scholar working on Endocrinology, Diabetes and Metabolism, Family Practice and Cell Biology, having authored 114 papers that have together received 9.6k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (58 papers), Pancreatic function and diabetes (27 papers), Diabetes Management and Research (23 papers), Metabolism, Diabetes, and Cancer (21 papers), Cellular transport and secretion (19 papers), Peptidase Inhibition and Analysis (16 papers), Heart Failure Treatment and Management (15 papers) and Cardiovascular Function and Risk Factors (9 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (5.2k citations), Cell Biology (2.0k citations) and Oncology (1.7k citations). Anja Schweizer has collaborated with scholars based in Switzerland, United States and Sweden. Frequent co-authors include S. Dejager, James E. Foley, Bo Åhrén, David Mills, Jack Rohrer, Hans-Peter Hauri, Stuart Kornfeld, Michelle A. Baron, H P Hauri and Jennifer Lippincott-Schwartz. Their work appears in journals such as Diabetes Obesity and Metabolism, Vascular Health and Risk Management, The Journal of Clinical Endocrinology & Metabolism, The Journal of Cell Biology and European Journal of Heart Failure.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.